A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)
This research study, called ACCLAIM-Lp(a), is testing a new medication called lepodisiran. The main goal is to see if lepodisiran can lower the risk of serious heart problems, like heart attacks and strokes, in adults who have high levels of a type of fat in their blood called lipoprotein(a) (Lp(a)). Participants selected for this study either already have heart disease or are at a high risk of developing it. The study drug will be given as an injection just under the skin. We're also looking to enrol more people to understand how different ways of giving the drug might affect Lp(a) levels. This is a Phase 3 trial, meaning it's one of the final steps before a drug might be considered for wider use.
במבט חטוף
על מה המחקר הזה?
This important research study, called ACCLAIM-Lp(a), is investigating a new medication called lepodisiran. The main purpose is to find out if this medicine can help lower the risk of serious heart and blood vessel problems, such as heart attacks and strokes, in people who have particularly high levels of a substance in their blood called lipoprotein(a), often shortened to Lp(a).
Lp(a) is a type of fat and protein found in your blood, and high levels of it have been linked to an increased risk of heart disease. While there are treatments for other types of cholesterol, there aren't many specific treatments for high Lp(a) yet. That's why this study is so important — it's exploring a new way to potentially protect people from future heart and stroke events.
The study will involve adults who either already have heart or blood vessel disease (like after a heart attack or needing a procedure to open blocked arteries) or who are considered at high risk of having a heart attack or stroke. Participants will be given the study medication, lepodisiran, as an injection under the skin. Another part of the study will involve additional participants to explore if giving the medicine in different ways can also effectively lower Lp(a) levels.
נקודות עיקריות
- This study tests a new drug, lepodisiran, for high lipoprotein(a).
- It aims to lower the risk of heart attacks and strokes.
- It's for adults with existing heart disease or those at high risk.
- The drug is given as an injection under the skin.
- Participation involves regular clinic visits and health monitoring.
- אתה יכול להפסיק להשתתף בכל עת.
מי עשוי להיות זכאי?
To join this study, you would need to meet certain requirements. Firstly, you must be 18 years or older and have a high level of lipoprotein(a) (Lp(a)) in your blood, specifically 175 nanomoles per litre or higher.
Secondly, you must either have existing heart or blood vessel disease (like heart disease or blockages in arteries) that has caused an event (like a heart attack) or required a procedure. Alternatively, if you are 55 years or older, you might be eligible if you are at high risk of a first heart attack or stroke. This could include having a known history of conditions like coronary artery disease, narrowing of major arteries, or blocked arteries in your legs, even if you haven't had an event yet. It could also apply if you have a family history of very high cholesterol (familial hypercholesteremia) or a combination of several other risk factors.
However, some conditions would mean you cannot take part. For example, if you've had a recent major heart event or surgery in the past two months, have very high blood pressure that isn't under control, severe heart failure, or have had a specific blood treatment called lipoprotein apheresis recently. Also, people with serious kidney or liver problems would not be suitable for this study.
האם מחקר זה יכול להתאים לך?
ענה על השאלות המהירות הללו כדי לבדוק אם אתה עשוי להיות זכאי. זהו מדריך בלבד — צוות המחקר מקבל את ההחלטה הסופית.
- האם אתה בן 18 או יותר?
- Do you have high lipoprotein(a) (Lp(a)) levels of 175 nmol/L or higher?
- Have you had a heart attack, stroke, or a procedure for blocked arteries, OR are you 55 or older with other heart risk factors?
- Have you NOT had a major heart event or surgery in the past 2 months?
- Do you have well-controlled blood pressure?
- Do you NOT have severe problems with your kidneys or liver?
מה כרוך בהשתתפות?
Taking part in this study would involve regularly visiting a clinic for health checks and to receive the study medication. This medicine, lepodisiran, will be given as an injection just under your skin. You will either receive the active drug or a placebo (a dummy drug with no active ingredients). This is decided randomly, like flipping a coin, and neither you nor your study doctor will know which you are receiving. The study team will monitor your health closely, including taking blood samples to check your Lp(a) levels and overall health. They will also keep track of any changes in your health or any new symptoms you experience. The total duration of your participation in the study, including all follow-up, will be discussed in detail by the study team.
סיכונים ותועלות פוטנציאליים
Locations (928)
- Birmingham Clinical Researchמיקוד מאומתבירמינגהם, ארצות הברית
- Alliance for Multispecialty Research, LLCמיקוד מאומתDaphne, United States
- מחקר קליני SECמיקוד מאומתדותן, ארצות הברית
- Alliance for Multispecialty Research, LLCמיקוד מאומתמובייל, ארצות הברית
- Mobile Heart Specialistsמיקוד מאומתמובייל, ארצות הברית
- Prime Medical Group, LLC dba Gilbert Center for Family Medicine, LLCמיקוד מאומתגילברט, ארצות הברית
- Mercy Gilbert Medical Centerמיקוד מאומתגילברט, ארצות הברית
- Sun City Clinical Researchמיקוד מאומתגלנדייל, ארצות הברית
- Elite Clinical Studies, LLCמיקוד מאומתפניקס, ארצות הברית
- Helios Clinical Research - Phoenixמיקוד מאומתפניקס, ארצות הברית
- Absolute Clinical Researchמיקוד מאומתפניקס, ארצות הברית
- Clinical Research Institute of Arizona (CRI) - Sun City Westמיקוד מאומתSun City West, United States
שאלות נפוצות
What is lipoprotein(a)?
Lipoprotein(a), or Lp(a), is a type of fat and protein particle in your blood. High levels of Lp(a) are linked to a higher risk of heart disease and stroke.
מדוע מחקר זה חשוב?
This study is important because there are currently limited treatments specifically for high Lp(a). It aims to find a new way to reduce heart disease and stroke risk.
What is a Phase 3 study?
A Phase 3 study is one of the final stages of clinical research. It involves a larger number of people to confirm the safety and effectiveness of a new drug before it can be considered for general use.
מהו פלצבו?
A placebo is a 'dummy' treatment that looks just like the study drug but has no active ingredients. It helps researchers compare the effects of the active drug to no treatment.
Will I know if I'm getting the actual drug or the placebo?
No, during the main part of the study, neither you nor your study doctor will know whether you are receiving the active drug or the placebo. This helps ensure unbiased results.
כיצד לגלות עוד
תמיד התייעץ עם רופא המשפחה או המומחה שלך לפני שתחליט להשתתף במחקר.
דיון
דיון קהילתי
מופעל על ידי הפורום שלנו ב community.patient.info. אנא היו מכבדים — זה אינו ייעוץ רפואי.